(Q44523988)

3 December 2017

Enzyme-mediated precipitation of parent drugs from their phosphate prodrugs (English)

1 reference

3 December 2017

Tycho Heimbach

1

1 reference

3 December 2017

Doo Man Oh

2

1 reference

3 December 2017

Lilian Y Li

3

1 reference

3 December 2017

Naír Rodríguez-Hornedo

4

1 reference

3 December 2017

George Garcia

5

1 reference

3 December 2017

David Fleisher

6

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

International Journal of Pharmaceutics

3 December 2017

1 reference

3 December 2017

261

1 reference

3 December 2017

81-92

1 reference

3 December 2017

1-2

1 reference

Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900287-4

7 January 2021

Polymorph screening: influence of solvents on the rate of solvent-mediated polymorphic transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900287-4

7 January 2021

Absorption rate limit considerations for oral phosphate prodrugs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900287-4

7 January 2021

Hydrolysis of pharmaceutically relevant phosphate monoester monoanions: correlation to an established structure-reactivity relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900287-4

7 January 2021

Enzymically mediated bioprecipitation of uranium by a Citrobacter sp. : a concerted role for exocellular lipopolysaccharide and associated phosphatase in biomineral formation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900287-4

7 January 2021

Effects of grinding and tableting on physicochemical stability of an anticancer drug, TAT-59.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900287-4

7 January 2021

Effects of water content on physical and chemical stability of tablets containing an anticancer drug TAT-59.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900287-4

7 January 2021

Estramustine Phosphate Sodium

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900287-4

7 January 2021

Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systems

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900287-4

7 January 2021

Reconversion of fosphenytoin in the presence of intestinal alkaline phosphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900287-4

7 January 2021

Molecular recognition at crystal interfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900287-4

7 January 2021

Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900287-4

7 January 2021

An integrated model for determining causes of poor oral drug absorption.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900287-4

7 January 2021

10.1016/S0378-5173(03)00287-4

Identifiers

DOI

1 reference

3 December 2017

1 reference